Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-256
Due: January 7, 2027
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-379
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-026
Due: January 7, 2027
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-098
Due: January 7, 2027
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-24-066
Due: January 7, 2027
Cancer Research Education Grants Program – Courses for Skills Development (R25 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
PAR-23-276
Due: January 7, 2027
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-378
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-069
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?